AIP Mutation in Pituitary Adenomas in the 18th Century and Today
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Gigantism results when a growth hormone-secreting pituitary adenoma is present before epiphyseal fusion. In 1909, when Harvey Cushing examined the skeleton of an Irish patient who lived from 1761 to 1783, he noted an enlarged pituitary fossa. We extracted DNA from the patient's teeth and identified a germline mutation in the aryl hydrocarbon-interacting protein gene (AIP). Four contemporary Northern Irish families who presented with gigantism, acromegaly, or prolactinoma have the same mutation and haplotype associated with the mutated gene. Using coalescent theory, we infer that these persons share a common ancestor who lived about 57 to 66 generations earlier.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“and acromegaly resulting from AIP gene mutations (20).”
From The Hippo signal transduction network for exercise physiologists (2016) · cites this paper as [20]
Citations
Cites
Microsatellites: simple sequences with complex evolution
Ellegren, H. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1348 · Cited by 2,441
Kingman, J. F. C. (1982) · Stochastic Processes and their Applications · doi:10.1016/0304-4149(82)90011-4 · Cited by 2,155
Melmed, S. (2006) · New England Journal of Medicine · doi:10.1056/nejmra062453 · Cited by 1,160
Acromegaly pathogenesis and treatment
Melmed, S. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39375 · Cited by 687
Pituitary Adenoma Predisposition Caused by Germline Mutations in the AIP Gene
Vierimaa, O., Georgitsi, M., Lehtonen, R., Vahteristo, P., Kokko, A., Raitila, A., Tuppurainen, K., Ebeling, T. M. L., Salmela, P. I., Paschke, R., et al. (2006) · Science · doi:10.1126/science.1126100 · Cited by 618
Genetic Discontinuity Between Local Hunter-Gatherers and Central Europe’s First Farmers
Bramanti, B., Thomas, M. G., Haak, W., Unterlaender, M., Jores, P., Tambets, K., Antanaitis-Jacobs, I., Haidle, M. N., Jankauskas, R., Kind, C.-J., et al. (2009) · Science · doi:10.1126/science.1176869 · Cited by 504
Self-citationA Concise History of World Population
Levine, D., & Livi-Bacci, M. (1994) · Journal of Interdisciplinary History · doi:10.2307/206347 · Cited by 375
A second-generation combined linkage–physical map of the human genome: Table 1.
Matise, T. C., Chen, F., Chen, W., De La Vega, F. M., Hansen, M., He, C., Hyland, F. C. L., Kennedy, G. C., Kong, X., Murray, S. S., et al. (2007) · Genome Research · doi:10.1101/gr.7156307 · Cited by 332
Daly, A. F., Vanbellinghen, J.-F., Khoo, S. K., Jaffrain-Rea, M.-L., Naves, L. A., Guitelman, M. A., Murat, A., Emy, P., Gimenez-Roqueplo, A.-P., Tamburrano, G., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2513 · Cited by 326
Krawczak, M., Ball, E. V., & Cooper, D. N. (1998) · The American Journal of Human Genetics · doi:10.1086/301965 · Cited by 319
Research works printed but not linked: 5
- Nordborg M. Coalescent theory. In: Balding DJ, Bishop M, Cannings C, eds. Handbook of statistical genetics. 3rd ed. Chichester, England: John Wiley, 2007:843-77.
- Marie P, 1886, Rev Med Liege, 6, 297
- Verga A, 1864, Sci Lett Bendiconti Clin Sci Mat Nat, 1, 111
- Minkowski O, 1887, Berl Klin Wochenschr, 21, 371
- Massalongo R, 1892, Riforma Med, 8, 74
Cited by
Recurrent gain-of-function USP8 mutations in Cushing's disease
Ma, Z.-Y., Song, Z.-J., Chen, J.-H., Wang, Y.-F., Li, S.-Q., Zhou, L.-F., Mao, Y., Li, Y.-M., Hu, R.-G., Zhang, Z.-Y., et al. (2015) · Cell Research · doi:10.1038/cr.2015.20 · Cited by 368
Beckers, A., Aaltonen, L. A., Daly, A. F., & Karhu, A. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1013 · Cited by 360
“(90) demonstrated that Charles Byrne’s gigantism (and enlarged pituitary fossa as shown by Cushing a century before) was also due to a p.”
BackgroundInfluentialEpidemiology and etiopathogenesis of pituitary adenomas
Aflorei, E. D., & Korbonits, M. (2014) · Journal of Neuro-Oncology · doi:10.1007/s11060-013-1354-5 · Cited by 229
“R304* nonsense mutation [108].”
Self-citationRostomyan, L., Daly, A. F., Petrossians, P., Nachev, E., Lila, A. R., Lecoq, A.-L., Lecumberri, B., Trivellin, G., Salvatori, R., Moraitis, A. G., et al. (2015) · Endocrine-Related Cancer · doi:10.1530/erc-15-0320 · Cited by 202
“Previous studies have noted that AIP mutations are associated with gigantism, either sporadic, within individual FIPA kindreds or in large historical studies (Naves et al. 2007, Jennings et al. 2009, Daly et al. 2010a, Chahal et al. 2011).”
BackgroundDénes, J., Swords, F., Rattenberry, E., Stals, K., Owens, M., Cranston, T., Xekouki, P., Moran, L., Kumar, A., Wassif, C., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3399 · Cited by 188
“Details of the microsatellites at the 11q13 locus (for MEN1) were previously described (15).”
Self-citationCazabat, L., Bouligand, J., Salenave, S., Bernier, M., Gaillard, S., Parker, F., Young, J., Guiochon-Mantel, A., & Chanson, P. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2291 · Cited by 185
Hernández-Ramírez, L. C., Gabrovska, P., Dénes, J., Stals, K., Trivellin, G., Tilley, D., Ferraù, F., Evanson, J., Ellard, S., Grossman, A. B., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1869 · Cited by 173
Self-citationTichomirowa, M. A., Barlier, A., Daly, A. F., Jaffrain-Rea, M.-L., Ronchi, C., Yaneva, M., Urban, J. D., Petrossians, P., Elenkova, A., Tabarin, A., et al. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0304 · Cited by 175
Novel pathway for somatostatin analogs in patients with acromegaly
Gadelha, M. R., Kasuki, L., & Korbonits, M. (2012) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2012.11.007 · Cited by 153
Self-citationAIP and its interacting partners
Trivellin, G., & Korbonits, M. (2011) · Journal of Endocrinology · doi:10.1530/joe-11-0054 · Cited by 158
“Pituitary apoplexy can be a presenting feature in patients with AIP mutation (Chahal et al. 2011).”
BackgroundSelf-citationSomatostatin Analogs Modulate AIP in Somatotroph Adenomas: The Role of the ZAC1 Pathway
Chahal, H., Trivellin, G., Leontiou, C. A., Alband, N., Fowkes, R. C., Tahir, A., Igreja, S., Chapple, J. P., Jordan, S., Lupp, A., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1111 · Cited by 150
Self-citationGrowth Hormone and Aging: Updated Review
Bartke, A. (2019) · The World Journal of Men's Health · doi:10.5534/wjmh.180018 · Cited by 134
“The rare syndrome of gigantism with excessive GH secretion starting before maturation appears to be associated with very high risk of early mortality, although the evidence consists primarily from case studies [82,83] and media reports.”
BackgroundWhat is complex about complex disorders?
Mitchell, K. J. (2012) · Genome Biology · doi:10.1186/gb-2012-13-1-237 · Cited by 115
“[121]; and the same is true for dwarfism at the other end of the”
BackgroundGenetic mutations in sporadic pituitary adenomas—what to screen for?
Lecoq, A.-L., Kamenický, P., Guiochon‐Mantel, A., & Chanson, P. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.181 · Cited by 103
The causes and consequences of pituitary gigantism
Beckers, A., Petrossians, P., Hanson, J., & Daly, A. F. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0114-1 · Cited by 79
Tumor microenvironment defines the invasive phenotype of AIP-mutation-positive pituitary tumors
Barry, S., Carlsen, E., Marques, P., Stiles, C. E., Gadaleta, E., Berney, D. M., Roncaroli, F., Chelala, C., Solomou, A., Herincs, M., et al. (2019) · Oncogene · doi:10.1038/s41388-019-0779-5 · Cited by 89
Self-citationMANAGEMENT OF ENDOCRINE DISEASE: Personalized medicine in the treatment of acromegaly
Kasuki, L., Wildemberg, L. E., & Gadelha, M. R. (2018) · European Journal of Endocrinology · doi:10.1530/eje-17-1006 · Cited by 81
Familial pituitary adenomas – who should be tested for AIP mutations?
Korbonits, M., Storr, H. L., & Kumar, A. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04445.x · Cited by 80
Self-citationTrivellin, G., Butz, H., Delhove, J. M. K. M., Igreja, S., Chahal, H., Živković, V., McKay, T. R., Patócs, A., Grossman, A. B., & Korbonits, M. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00546.2011 · Cited by 88
“Mutations affecting AIP were shown to be involved in the predisposition to develop a familial form of pituitary adenoma, although such mutations do not seem to play a role in the pathogenesis of sporadic tumors (12, 13, 38, 63).”
BackgroundSelf-citationMorgan, R. M. L., Hernández-Ramírez, L. C., Trivellin, G., Zhou, L., Roe, S. M., Korbonits, M., & Prodromou, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0053339 · Cited by 71
Self-citationGenetics of Acromegaly and Gigantism
Bogusławska, A., & Korbonits, M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10071377 · Cited by 85
“Several sets of founder mutations have been identified, such as the original cohort of Finnish patients (Q14* mutation) [35], but also Italian (R304*) [44], English (a small duplication mutation) [45] and Northern Irish (R304* independent from the Italian) cohorts, the latter providing a genetic background to the hist…”
BackgroundSelf-citationD’Angelo, D., Müssnich, P., Sepe, R., Raia, M., Vecchio, L. D., Cappabianca, P., Pellecchia, S., Petrosino, S., Saggio, S., Solari, D., et al. (2019) · Journal of Molecular Medicine · doi:10.1007/s00109-019-01789-7 · Cited by 71
“Several genetic alterations have been already identified in PAs: activating mutations of guanine nucleotide-binding protein α subunit (GNAS) in somatotroph adenomas [6]; Aryl hydrocarbon receptor-interacting protein (AIP) mutations in sporadic PAs and Familial Isolated Pituitary Adenomas [7]; somatic mutations in Ubiq…”
BackgroundWilliams, F. E., Hunter, S. J., Bradley, L., Chahal, H., Storr, H. L., Akker, S. A., Kumar, A., Orme, S. M., Evanson, J., Abid, N., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2868 · Cited by 63
Self-citationSomatic and germline mutations in the pathogenesis of pituitary adenomas
Vandeva, S., Daly, A., Pétrossians, P., Zacharieva, S., & Beckers, A. M. (2019) · European Journal of Endocrinology · doi:10.1530/eje-19-0602 · Cited by 69
Genetic Aspects of Pituitary Adenomas
Marques, P., & Korbonits, M. (2017) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2017.01.004 · Cited by 62
Self-citationde Herder, W. W. (2015) · Neuroendocrinology · doi:10.1159/000371808 · Cited by 58
Aggressive tumor growth and clinical evolution in a patient with X-linked acro-gigantism syndrome
Naves, L. A., Daly, A., Dias, L. A., Yuan, B., Zakir, J. C. D. O., Barra, G. B., Palmeira, L., Villa, C., Trivellin, G., Jreige, A., et al. (2015) · Endocrine · doi:10.1007/s12020-015-0804-6 · Cited by 58
Germline and mosaic mutations causing pituitary tumours: genetic and molecular aspects
Pepe, S., Korbonits, M., & Iacovazzo, D. (2018) · Journal of Endocrinology · doi:10.1530/joe-18-0446 · Cited by 64
Self-citationChanson, P., Salenave, S., & Kamenický, P. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-59602-4.00014-9 · Cited by 62
The Hippo signal transduction network for exercise physiologists
Gabriel, B. M., Hamilton, D. L., Tremblay, A. M., & Wackerhage, H. (2016) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01076.2015 · Cited by 48
“Examples for the latter are dwarfism caused by FGFR3 mutations (37), and acromegaly resulting from AIP gene mutations (20).”
BackgroundPituitary Medicine From Discovery to Patient-Focused Outcomes
Melmed, S. K. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3653 · Cited by 47
Hernández-Ramírez, L. C., Morgan, R. M. L., Barry, S., D’Acquisto, F., Prodromou, C., & Korbonits, M. (2018) · Oncotarget · doi:10.18632/oncotarget.24183 · Cited by 46
“Founder effect in the Northern Irish [133, 134] and Northern Italian [135] populations.”
BackgroundSelf-citationPersonnier, C., Cazabat, L., Bertherat, J. Y., Gaillard, S., Souberbielle, J., Habrand, J. L., Dufour, C., Clauser, É., Sainte‐Rose, C., & Polak, M. (2011) · Hormone Research in Paediatrics · doi:10.1159/000327831 · Cited by 41
An Update on Pituitary Neuroendocrine Tumors Leading to Acromegaly and Gigantism
Asa, S. L., & Ezzat, S. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10112254 · Cited by 38
“This ay be because they grow faster and are more structurally aggressive but may also be due to the fact that they appear to be the hallmark of patients with germline AIP mutations, i cluding the early onset giants [35].”
BackgroundShould the skeleton of "the Irish giant" be buried at sea?
Doyal, L., & Muinzer, T. L. (2011) · BMJ · doi:10.1136/bmj.d7597 · Cited by 36
Management of macroprolactinomas
Tirosh, A., & Shimon, I. (2015) · Clinical Diabetes and Endocrinology · doi:10.1186/s40842-015-0006-4 · Cited by 33
“Prolactin-secreting adenomas were reported in the context of the Familial Isolated Pituitary Adenoma (FIPA) syndrome linked to AIP gene mutation, although it is usually associated with acromegaly [77–79].”
BackgroundAIP mutations in young patients with acromegaly and the Tampico Giant: the Mexican experience
Ramírez‐Rentería, C., Hernández-Ramírez, L. C., Portocarrero-Ortiz, L. A., Vargas‐Ortega, G., Melgar, V., Espinosa-Cárdenas, E., Espinosa-de-los-Monteros, A. L., Sosa, E., González‐Virla, B., Zúñiga, S., et al. (2016) · Endocrine · doi:10.1007/s12020-016-0930-9 · Cited by 32
Self-citationMicroRNAs and Target Genes in Pituitary Adenomas
Feng, Y., Mao, Z.-G., Wang, X., Du, Q., Jian, M., Zhu, D., Xiao, Z., Wang, H., & Zhu, Y. (2018) · Hormone and Metabolic Research · doi:10.1055/s-0043-123763 · Cited by 33
“The lack of AIP was closely related to the occurrence of pituitary adenoma [51, 52] and was commonly found in patients with acromegaly and gigantism [53].”
BackgroundNezhad, F. Y., Verbrugge, S. A. J., Schönfelder, M., Becker, L., de Angelis, M. H., & Wackerhage, H. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00262 · Cited by 32
“Human body height is additionally influenced by rare, large-effect size mutations of genes such as mutations of AIP that cause gigantism (Chahal et al., 2011) or mutations of genes such as FGFR3 that can cause dwarfism (Foldynova-Trantirkova et al.”
BackgroundMANAGEMENT OF ENDOCRINE DISEASE: GH excess: diagnosis and medical therapy
Andersen, M. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0532 · Cited by 29
Increased Population Risk ofAIP-Related Acromegaly and Gigantism in Ireland
Radian, S., Diekmann, Y., Gabrovska, P. N., Holland, B., Bradley, L., Wallace, H. J., Stals, K. L., Bussell, A.-M., McGurren, K., Cuesta, M., et al. (2016) · Human Mutation · doi:10.1002/humu.23121 · Cited by 29
“R304∗ or R304∗) in six FIPA pedigrees of Irish ancestry, including individuals born in the 18th and 20th centuries, in a small region within Mid Ulster, Northern Ireland (NI) [Chahal et al., 2011; Stals et al., 2011].”
BackgroundMethodResultInfluentialSelf-citationScreening for AIP gene mutations in a Han Chinese pituitary adenoma cohort followed by LOH analysis
Cai, F., Zhang, Y., Zhao, X., Yang, Y., Ma, S., Dai, C., Liu, X., Yao, Y., Feng, M., Wei, J., et al. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0442 · Cited by 29
Iacovazzo, D., Hernández-Ramírez, L. C., & Korbonits, M. (2017) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2017.1306439 · Cited by 29
Self-citationAIPMutation in Pituitary Adenomas
Cazabat, L., Bouligand, J., & Chanson, P. (2011) · New England Journal of Medicine · doi:10.1056/nejmc1101859 · Cited by 29
Melmed, S. K., & Kleinberg, D. L. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00009-5 · Cited by 39
Acromegaly: Assessing the Disorder and Navigating the Therapeutic Options for Treatment
Melmed, S. K., Kleinberg, D. L., Bonert, V. S., & Fleseriu, M. (2014) · Endocrine Practice · doi:10.4158/ep14430.ra · Cited by 30
Theodorou, J., Nowak, E., Böck, A., Salvermoser, M., Beerweiler, C., Zeber, K., Kulig, P., Tsang, M. S., Wong, C., Wong, G., et al. (2021) · Pediatric Allergy and Immunology · doi:10.1111/pai.13657 · Cited by 29
Pituitary gigantism: update on molecular biology and management
Lodish, M. B., Trivellin, G., & Stratakis, C. A. (2015) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000212 · Cited by 25
Muinzer, T. L. (2013) · International Journal of Cultural Property · doi:10.1017/s094073911200046x · Cited by 24
Genetics of pituitary adenomas
Korbonits, M., & Shaid, M. (2017) · Neurology India · doi:10.4103/neuroindia.ni_330_17 · Cited by 24
Self-citationAlband, N., & Korbonits, M. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-59602-4.00023-x · Cited by 24
Self-citationFamilial isolated pituitary adenomas: An emerging clinical entity
Martucci, F., Trivellin, G., & Korbonits, M. (2012) · Journal of Endocrinological Investigation · doi:10.1007/bf03346742 · Cited by 22
Self-citationGuaraldi, F., Corazzini, V., Gallia, G. L., Grottoli, S., Stals, K. L., Dalantaeva, N. S., Frohman, L. A., Korbonits, M., & Salvatori, R. (2012) · Pituitary · doi:10.1007/s11102-012-0391-y · Cited by 22
Self-citationHuman Growth and Growth Hormone: From Antiquity to the Recominant Age to the Future
Graber, E., Reiter, E. O., & Rogol, A. D. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.709936 · Cited by 25
“Marta Korbonits and co-workers have nicely summarized the story of the Irish Giant in its historical context and defined the molecular defect in the aryl hydrocarbon-interacting protein gene (AIP) that causes excessive growth hormone secretion before pubertal maturation and epiphyseal closure, hence gigantism and late…”
BackgroundYarman, S., Öğret, Y., & Oğuz, F. S. (2015) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2014.0333 · Cited by 21
“3 and several inactivating mutations have been identified to date, which cause the development of familial or sporadic pituitary adenomas (Daly et al., 2006, 2007; Barlier et al., 2007; Cazabat et al., 2007; Igreja et al., 2010; Occhi et al., 2010; Chahal et al., 2011; Beckers et al., 2013).”
BackgroundThe Genetic Pathophysiology and Clinical Management of the TADopathy, X-Linked Acrogigantism
Daly, A., & Beckers, A. M. (2024) · Endocrine Reviews · doi:10.1210/endrev/bnae014 · Cited by 22
Lloyd, C., & Grossman, A. B. (2013) · Endocrine · doi:10.1007/s12020-013-0125-6 · Cited by 20
“An R304X mutation was found following DNA analysis in an 18th century Northern Irish giant’s skeleton, and was also identified in several local Northern Irish families today [17]; haplotype analysis suggests a common ancestor around 1,500 years ago [17].”
BackgroundSelf-citationThree Reportedly Unrelated Families With Liddle Syndrome Inherited From a Common Ancestor
Pagani, L., Diekmann, Y., Sazzini, M., Fanti, S. D., Rondinelli, M., Farnetti, E., Casali, B., Caretto, A., Novara, F., Zuffardi, O., et al. (2017) · Hypertension · doi:10.1161/hypertensionaha.117.10491 · Cited by 22
Self-citationPhosphodiesterases and cAMP Pathway in Pituitary Diseases
Bizzi, M. F., Bolger, G. B., Korbonits, M., & Ribeiro‐Oliveira, A. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00141 · Cited by 18
Self-citationIdentification of a novel somatic mutation of POU6F2 by whole‐genome sequencing in prolactinoma
Miao, Y., Li, C., Guo, J., Wang, H., Gong, L., Xie, W., & Zhang, Y. (2019) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.1022 · Cited by 18
AIP variant causing familial prolactinoma
Carty, D., Harte, R., Drummond, R. S., Ward, R., Magid, K. S., Collier, D., Owens, M., & Korbonits, M. (2020) · Pituitary · doi:10.1007/s11102-020-01085-5 · Cited by 18
Self-citationBao, X., Wang, G., Yu, S., Sun, J. H., He, L., Zhao, H.-L., Ma, Y., Wang, F., Wang, X., Wang, R., et al. (2020) · Theranostics · doi:10.7150/thno.47525 · Cited by 21
“Pituitary neuroendocrine tumors (PitNEts) are common intracranial and neuroendocrine tumors that arise mostly in a sporadic manner and only a minority of adenomas is part of hereditary or familial syndromes [1, 2].”
BackgroundMarques, N. V., Kasuki, L., Coelho, M. C. A., Lima, C. H. D. A., Wildemberg, L. E., & Gadelha, M. R. (2017) · Journal of Endocrinological Investigation · doi:10.1007/s40618-017-0725-8 · Cited by 18
Medical Museums Past, Present and Future
Alberti, S. (2011) · Bulletin of The Royal College of Surgeons of England · doi:10.1308/147363511x552548 · Cited by 18
A differential diagnosis of inherited endocrine tumors and their tumor counterparts
Toledo, S. P. A., Lourenço, D. M., & Toledo, R. A. (2013) · Clinics · doi:10.6061/clinics/2013(07)24 · Cited by 18
“Similarly, a founding couple could be traced in a FIPA family from Ireland to the 18 century (65).”
BackgroundInfluentialKaraca, Z., Taheri, S., Tanrıverdi, F., Unluhizarci, K., & Keleştimur, F. (2015) · Pituitary · doi:10.1007/s11102-015-0659-0 · Cited by 16
“Acromegalic patients who carry an AIP were shown to require reoperation and/or radiotherapy more frequently [4, 23, 24] and both hormonal and tumoral response to SSA was found to be less in these patients [4].”
BackgroundHereditary Pituitary Tumor Syndromes: Genetic and Clinical Aspects
García-Guzmán, B., Portocarrero-Ortiz, L. A., Dorantes-Argandar, A., & Mercado, M. (2020) · Revista de investigaci�n Cl�nica · doi:10.24875/ric.19003186 · Cited by 15
Mehta, G. U., & Jane, J. A. (2012) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3283587bed · Cited by 15
Rostomyan, L., Potorac, I., Beckers, P., Daly, A., & Beckers, A. M. (2017) · Annales d Endocrinologie · doi:10.1016/j.ando.2017.04.012 · Cited by 14
Salvatori, R., Radian, S., Diekmann, Y., Iacovazzo, D., David, A., Gabrovska, P. N., Grassi, G., Bussell, A.-M., Stals, K. L., Weber, A. P., et al. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0293 · Cited by 14
Self-citationThe role of AIP mutations in pituitary adenomas: 10 years on
Daly, A., & Beckers, A. M. (2016) · Endocrine · doi:10.1007/s12020-016-1194-0 · Cited by 14
On the Origins of Pituitary Apoplexy
Pearce, J. M. S. (2015) · European Neurology · doi:10.1159/000431090 · Cited by 15
Niyazoğlu, M., Sayitoğlu, M., Fırtına, S., Hatipoğlu, E., Gazioğlu, N., & Kadıoğlu, P. (2013) · Pituitary · doi:10.1007/s11102-013-0493-1 · Cited by 13
“R304X has been reported from nine different countries so far [11, 13, 16, 17, 26, 27].”
BackgroundGrowth Hormone and Insulin-Like Growth Factor I: Effects on the Brain
Laron, Z. (2009) · Elsevier eBooks · doi:10.1016/b978-008088783-8.00078-4 · Cited by 13
Familial Pediatric Endocrine Tumors
Millar, S., Bradley, L., Donnelly, D. E., Carson, D. J., & Morrison, P. J. (2011) · The Oncologist · doi:10.1634/theoncologist.2011-0120 · Cited by 12
Self-citationHereditary Gigantism-the biblical giant Goliath and his brothers.
Donnelly, D. E., & Morrison, P. J. (2014) · PubMed Central · Cited by 12
Self-citationCongenital anomalies of the limbs in mythology and antiquity
Mavrogenis, A. F., Markatos, K., Nikolaou, V. S., Gartziou-Tatti, A., & Soucacos, P. N. (2018) · International Orthopaedics · doi:10.1007/s00264-018-3776-3 · Cited by 11
Tuncer, F. N., Doğanşen, S. Ç., Serbest, E., Tanrıkulu, S., Ekici, Y., Bılgıç, B., & Yarman, S. (2018) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2018.0133 · Cited by 11
“…in association with the development of independent familial or sporadic PAs (Daly et al. , 2006, 2007; Barlier et al. , 2007; Cazabat et al. , 2007, 2012; Georgitsi et al. , 2007; Igreja et al. , 2010; Occhi et al. , 2010a; Chahal et al. , 2011; Tichomirowa et al. , 2011; Beckers et al. , 2013).”
Loughrey, P. B., & Korbonits, M. (2019) · Experientia supplementum · doi:10.1007/978-3-030-25905-1_10 · Cited by 13
Self-citationFamilial Isolated Pituitary Adenomas
Chahal, H., Kumar, V. K. A., & Korbonits, M. (2009) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2009.05.00.55 · Cited by 12
Self-citationA case of acromegaly (Greece, 7th century AD)
Charlier, P., & Tsigonaki, C. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0712 · Cited by 10
Combination of Klinefelter Syndrome and Acromegaly: A Rare Case Report
Fang, H., Xu, J., Wu, H., Fan, H., & Zhong, L. (2016) · Medicine · doi:10.1097/md.0000000000003444 · Cited by 11
Nass, R. M., & Evans, W. S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-47912-7.00020-2 · Cited by 11
de Herder, W. W. (2012) · Clinics · doi:10.6061/clinics/2012(sup01)06 · Cited by 9
“Using coalescent theory, they came to the conclusion that these persons share a common ancestor who lived about 57–66 generations earlier (69).”
Nganga, H. K., & Lubanga, R. P. (2013) · Pan African Medical Journal · doi:10.11604/pamj.2013.15.39.2054 · Cited by 8
“Causal contributors to pituitary tumor development include heredity, hormonal influence and genetic mutations [2].”
BackgroundReassessing the role of the p.(Arg304Gln) missense AIP variant in pituitary tumorigenesis
Loughrey, P. B., Mothojakan, N. B., Iacovazzo, D., Arni, A. M., Aflorei, E. D., Arnaldi, G., Barlier, A., Beckers, A. M., Bizzi, M. F., Chanson, P., et al. (2025) · European Journal of Endocrinology · doi:10.1093/ejendo/lvaf044 · Cited by 8
Self-citationMolecular genetic advances in pituitary tumor development
Yates, C. J., Lines, K. E., & Thakker, R. V. (2014) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2015.955795 · Cited by 7
“FIPA is an autosomal dominant disorder with incomplete penetrance (~30%), due to mutations of the aryl hydrocarbon receptor interacting protein (AIP) gene which is located at 11q13 and consists of 6 exons encoding a highly conserved 330 amino acid protein (TABLE 2) [45,46].”
BackgroundAIP gene germline variants in adult Polish patients with apparently sporadic pituitary macroadenomas
Trofimiuk–Müldner, M., Domagała, B., Sokołowski, G., Skalniak, A., & Hubalewska–Dydejczyk, A. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1098367 · Cited by 7
“Low AIP protein expression is a better predictor of GHsecreting tumor aggressiveness than high Ki-67 index or p53 expression (4, 17, 18).”
BackgroundHu, Y., Yang, J., Chang, Y.-K., Ma, S., & Qi, J.-F. (2016) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2016.3002 · Cited by 7
“Subsequent to the initial study (8), a series of mutations in the AIP gene were discovered in patients with sporadic or familial pituitary adenomas from various populations (9-17).”
AIP Mutation in Pituitary Adenomas in the 18th Century and Today
Eugster, E. A. (2011) · Yearbook of Endocrinology · doi:10.1016/j.yend.2011.04.007 · Cited by 7
Making kinship with human remains: Repatriation, biomedicine and the many relations of Charles Byrne
Nash, C. (2018) · Environment and Planning D Society and Space · doi:10.1177/0263775818756080 · Cited by 7
Jackson, I., Mattiangeli, V., Cassidy, L. M., Murphy, E., & Bradley, D. G. (2022) · European Journal of Human Genetics · doi:10.1038/s41431-022-01219-2 · Cited by 7
“For example, an 18th century skeleton of an extremely tall individual had sufficiently intact DNA for targeted PCR of a gigantism-associated locus(14).”
BackgroundAcromegalic gigantism, physicians and body snatching. Past or present?
de Herder, W. W. (2012) · Pituitary · doi:10.1007/s11102-012-0389-5 · Cited by 7
“Using coalescent theory, they infer that these persons share a common ancestor who lived about 57–66 generations earlier [19].”
Iwata, T., Yamada, S., Itô, J., Inoshita, N., Mizusawa, N., Ono, S., & Yoshimoto, K. (2014) · Endocrine Pathology · doi:10.1007/s12022-014-9318-7 · Cited by 7
Bradley, L., & Morrison, P. J. (2011) · PubMed Central · Cited by 6
Self-citationWe cannot change the past, but we can learn from it
Smith, M., Knüsel, C. J., Chamberlain, A. T., & Mitchell, P. D. (2012) · BMJ · doi:10.1136/bmj.e556 · Cited by 6
Ertörer, M. E., Tuncer, F. N., Doğanşen, S. Ç., Tanrıkulu, S., Selçukbiricik, Ö. S., Topaloğlu, Ö., Evran, M., Kadıoğlu, P., Aydin, S., Canbaz, B., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-08610-1 · Cited by 5
“The Arg304Ter mutation, located in the hotspot region of AIP , was most frequently reported in FIPAs from Ireland, Romania, Britain, Italy, USA, India and Mexico, while Arg81Ter mutation had been reported in families from Brazil, USA, India and the UK 10,12,26–29 .”
Genetics of Pituitary Tumor Syndromes
Daly, A., & Beckers, A. M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804169-7.00021-0 · Cited by 5
AIP Mutation in Pituitary Adenomas in the 18th Century and Today
Ludlam, W. H. (2011) · Yearbook of Endocrinology · doi:10.1016/j.yend.2011.06.061 · Cited by 5
Genetic and metabolic characteristics of familial isolated pituitary adenomas
Dalantaeva, N. S., & Dedov, I. I. (2013) · Obesity and metabolism · doi:10.14341/2071-8713-4817 · Cited by 5
Metadata
- Authors
- Chahal, H. S., Stals, K., Unterländer, M., Balding, D. J., Thomas, M. G., Kumar, A. V., Besser, G. M., Atkinson, A. B., Morrison, P. J., Howlett, T. A., Levy, M. J., Orme, S. M., Akker, S. A., Abel, R. L., Grossman, A. B., Burger, J., Ellard, S., & Korbonits, M.
- Affiliations
- Queen Mary University of London (GB)
- Royal Devon & Exeter NHS Foundation Trust (GB)
- Johannes Gutenberg University Mainz (DE)
- University College London (GB)
- Uppsala University (SE)
- Great Ormond Street Hospital (GB)
- Royal Victoria Hospital (CA)
- Belfast Health and Social Care Trust (GB)
- University Hospitals of Leicester NHS Trust (GB)
- St James's University Hospital (GB)
- Natural History Museum (GB)
- University of Exeter (GB)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2011-01-06
- Volume
- 364
- Issue
- 1
- Pages
- 43-50
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2102759045
- Cited by
- 163
- References
- 29
- Citations by year
- 2026: 7 · 2025: 7 · 2024: 2 · 2023: 2 · 2022: 7 · 2021: 11 · 2020: 5 · 2019: 10 · 2018: 12 · 2017: 12 · 2016: 14 · 2015: 13 · 2014: 10 · 2013: 16 · 2012: 17
- FWCI
- 15.20
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Figshare (submittedVersion)
- Open Research Exeter (University of Exeter) (submittedVersion)
- Research Portal (Queen's University Belfast) (submittedVersion)
- Funders
- Royal College of Surgeons of England
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Social Sciences › Arts and Humanities › Archeology (arts and humanities) › Paleopathology and ancient diseases
- Keywords
- AIP gene, germline mutations, pituitary adenoma, gigantism, acromegaly, prolactinoma, Harvey Cushing, historical case, haplotypes, coalescent analysis, founder effect
- MeSH terms
- Acromegaly, Adenoma, Gigantism, Haplotypes, Heterozygote, Humans, Male, Mutation, Pedigree, Pituitary Neoplasms, Prolactinoma, Sequence Analysis, DNA, Microsatellite Repeats, Intracellular Signaling Peptides and Proteins, History, 18th Century, Growth Hormone-Secreting Pituitary Adenoma
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.